An Indianapolis medical-software firm is expanding its reach into the fast-growing areas of opioid prescription management and precision medicine, in which treatment is determined in part by genetic testing.
bostic-brad-mug-tech-executive.jpg Bostic
Hc1.com recently raised $10 million in venture funding and is launching two cloud-based products this month that will “transform and personalize the way health care is delivered,” said Brad Bostic, who founded the firm in 2011 and is chairman and CEO.
